Telomeres and telomerase in human leukemias

Leukemia

Volumn 10, Issue 8, 1996, Pages 1255-1261

  Shay, J W ^a   Werbin, H ^a   Wright, W E ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

ALL; AML; Cellular senescence; CLL; CML; Immortality; MDS

Indexed keywords

RIBONUCLEOPROTEIN;

CELL AGING; CELL DIVISION; CHROMOSOME SIZE; HUMAN; LEUKEMIA; PRIORITY JOURNAL; SENESCENCE; SHORT SURVEY; TELOMERE;

EID: 0029748585     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (59)

1. Blackburn EH. Telomeres. Trends Biol Sci 1991: 16: 378-381.
2. Blackburn EH. Structure and function of telomeres. Nature 1991; 350: 569-573.
3. Tommerup H, Dousmanis A, de Lange T. Unusual chromatin in human telomeres. Mod Cell Biol 1994; 14: 5777-5785.
4. Lejnine S, Makarov VL, Langmore JP. Conserved nucleoprotein structure at the ends of vertebrate and invertebrate chromosomes. Proc Natl Acad Sci USA 1995; 92: 2393-2397.
5. n, present at the telomeres of human chromosomes. Proc Natl Acad Sci USA 1988; 85: 6622-6626.
6. Olovnikov AM. Principles of marginotomy in template synthesis of polynucleotides. Doklady Akademii Nauk SSSR 1971; 201: 1496-1499.
7. Watson JD. Origin of concatameric T4 DNA. Nature 1972; 239: 197-201.
8. Olovnikoff AM. A theory of marginotomy. J Theor Biol 1973; 41: 181-190.
9. Counter C, Botelho F, Wang R, Harley C, Bacchetti S. Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. J Virol 1994; 68: 3410-3413.
10. Harley CB, Futcher BA, Greider CW. Telomeres shorten during aging of human fibroblasts. Nature 1990; 345: 458-460.
11. Lindsey J, McGill NI, Lindsey LA, Green DK, Cooke HJ. In vivo loss of telomeric repeats with age in humans. Mut Res 1991; 256: 45-48.
12. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, Greider CW, Harley CB. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 1992; 89: 10114-10118.
13. deLange T, Shiue L, Meyers RM, Cox DR, Naylor SL, Killery AM, Varmus HE. Structure and variability of human chromosome ends. Mol Cell Biol 1990; 10: 518-527.
14. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC. Telomere reduction in human colorectal carcinoma and with ageing. Nature 1990; 346: 866-868.
15. Shay JW, Brasiskyte D, Oullette M, Piatyszek MA, Werbin H, Ying Y, Wright WE. Analysis of telomerase and telomerases. In: Adolph KW (ed). Gene and Chromosome Analysis Part C. Academic Press: San Diego, 1994, pp 263-280.
16. Zakian VA. Structure and function of telomeres. Annu Rev Genet 1989; 23: 579-604.
17. Shay JW, Werbin H, Wright WE. You haven't heard the end of it: telomere loss may link human aging with cancer. Can J Aging 1995; 14: 511-524.
18. Harley CB. Telomere loss: mitotic clock or genetic time bomb? Mutat Res 1991; 256: 271-282.
19. Bacchetti S, Counter CM. Telomerase: a key to cell immortality: review. Int J Oncol 1995; 7: 423-432.
20. Hiyama E, Yokoyama T, Hiyama K, Yamakido M, Santo T, Kodama T, Ichikawa T, Matsuura Y. Alteration of telomeric repeat length in adult and childhood solid neoplasias. Int J Oncol 1995; 6: 13-16.
21. Vaziri H, Schachter F, Uchida I, Wei L, Zhu X, Effros R, Cohen D, Harley CB. Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am J Hum Genet 1993; 52: 661-667.
22. Greider CW, Blackburn EH. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 1985; 43: 405-413.
23. Blackburn EH. Telomerases. Annu Rev Biochem 1992; 61: 113-129.
24. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, Coviello GM, Wright WE, Weinrich SL, Shay JW. Specific association of human telomerase activity with immortal cells and cancer. Science 1995; 266: 2011-2015.
25. Piatyszek MA, Kim NW, Weinrich SL, Hiyama K, Hiyama E, Wright WE, Shay JW. Detection of telomerase activity in human cells and tumors. Meth Cell Sci 1995; 17: 1-15.
26. Counter CM, Hirte HW, Bacchetti S, Harley CB. Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci USA 1994; 91: 2900-2904.
27. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW. Correlating telomerase activity levels with human neuroblastoma outcomes. Nature Med 1995; 1: 249-255.
28. Hiyama K, Hiyama E, Ishioka S, Yamakido M, Inai K, Gazdar AF, Piatyszek MA, Shay JW. Telomerase activity in small-cell and non-small-cell lung cancer. J Natl Cancer Inst 1995; 87: 895-902.
29. Counter CM, Gupta J, Harley CB, Leber B, Bacchetti S. Telomerase activity in normal leukocytes and hematologic malignancies. Blood 1995; 85: 2315-2320.
30. Broccoli D, Young JW, deLange T. Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA 1995; 92: 9082-9086.
31. Wright WE, Shay JW, Piatyszek MA. Modification of a telomeric repeat amplification protocol (TRAP) result in increased reliability linearity and sensitivity. Nucleic Acids Res 1995; 23: 3794-3795.
32. Shay JW. Aging and cancer: are telomeres and telomerase the connection? Mol Med Today 1995; 1: 378-384.
33. Shay JW, Wright WE. Telomerase activity in human cancer. Curr Opin Oncol 1996; 8: 66-71.
34. Shay JW, Wright WE, Werbin H. Defining the molecular mechanism of human cell immortalization. Biochim Biophys Acta 1991; 1072: 1-7.
35. Shay JW, Peirera-Smith O, Wright WE. A role for both Rb and p53 in the regulation of cellular senescence. Exp Cell Res 1991; 196: 33-39.
36. Counter CM, Avilion AA, LeFeuvre CE, Stewart NC, Greider CW, Harley CB, Bacchetti S. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992; 11: 1921-1929.
37. Shay JW, Wright WE, Brasiskyte D, Van der Haegen BA. E6 of human papillomavirus type 16 can overcome the M1 stage of immortalization in human mammary epithelial cells but not in human fibroblasts. Oncogene 1993; 8: 1407-1413.
38. Allsopp RC, Harley CB. Evidence of a critical telomere length in senescent human fibroblasts. Exp Cell Res 1995; 219: 130-136.
39. Harley CB. Telomeres and aging: fact, fancy, and the future. J NIH Res 1995; 7: 64-68.
40. Holt SE, Wright WE, Shay JW. Regulation of telomerase activity in immortal human cell lines. Mol Cell Biol 1996; (in press).
41. Mantell LL, Greider CW. Telomerase activity in germline and embryonic cells of Xenopus. EMBO J 1994; 13: 3211-3217.
42. Sharma HW, Sokoloski JA, Perez JR, Maltese JY, Sartorelli AC, Stein CA, Nichols C, Khaled Z, Telang NT, Narayanan R. Differentiation of immortal cells inhibits telomerase activity. Proc Natl Acad Sci USA 1995; 92: 12343-12346.
43. Zhang W, Piatyszek MA, Kobayashi T, Estey E, Andreeff M, Deisseroth AB, Wright WE, Shay JW. Telomerase activity in human acute myelogenous leukemia: inhibition of telomerase activity by differentiation-inducing agents. Clin Cancer Res 1996; (in press).
44. Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Landsdorp PM. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci USA 1994; 91: 9857-9860.
45. Chui CP, Dragowska W, Kim NW, Vaziri H, Yui J, Thomas TE, Harley CB, Landsdorf PM. Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow. Stem Cells 1996; 14: 239-248.
46. Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, Piatyszek MA, Shay JW, Ishiaka S, Yamakido M. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995; 155: 3711-3715.
47. Weng N-P, Levine BL, June CH, Hodes RJ. Human naive and memory T lymphocytes differ in telomeric length and replicative potential. Proc Natl Acad Sci USA 1995; 92: 11091-11094.
48. Adamson DJ, King DJ, Haites NE. Significant telomere shortening in childhood leukemia. Cancer Genet Cytogenet 1992; 61: 204-206.
49. Yamada O, Oshimi K, Motoji T, Mizoguchi H, Telomeric DNA in normal and leukemic blood cells. J Clin Invest 1995; 95: 1117-1123.
50. Takauchi K, Tashiro S, Ohtaki M, Kamada N. Telomere reduction of specific chromosome translocation in acute myelocytic leukemia. Jpn J Cancer Res 1994; 85: 127-130.
51. Ohyashiki JH, Ohyashiki K, Fujimura T, Kawakubo K, Shimamoto T, Iwabuchi A, Toyama K. Telomere shortening associated with disease evolution patterns in myelodysplastic syndromes. Cancer Res 1994; 54: 3557-3560.
52. Gottschling DE. Telomere-proximal DNA in Saccharomyces cerevisiae is refractory to methyltransferase activity in vivo. Proc Natl Acad Sci USA 1992; 89: 4062-4065.
53. Wright WE, Shay JW, Telomere positional effects and the regulation of cellular senescence. Trends Genet 1991; 8: 193-197.
54. Feng J, Funk WD, Wang S-S, Weinrich SL, Avilion AA, Chiu C-P, Adams RR, Chang E, Allsopp RC, Yu J, Le S, West MD, Harley CB, Andrews WH, Greider CW, Villeponteau B. The RNA component of human telomerase. Science 1995; 269: 1236-1241.
55. Collins K, Kobayashi R, Greider C. Purification of Tetrahymena telomerase and cloning the genes encoding the two protein components of the enzyme. Cell 1995; 81: 677-686.
56. Chong L, Steensel BV, Broccoli D, Erdjument-Bromage H, Hanish J, Tempst P, de Lange T. A human telomeric protein. Science 1995; 270: 1633-1667.
57. de Lange T. Human telomeres are associated to the nuclear matrix. EMBO J 1992; 11: 717-724.
58. Zalensky AO, Allen MJ, Kobayashi A, Zalenskaya IA, Balhorn R, Bradbury EM. Well-defined genome architecture in human sperm nucleus. Chromosoma 1995; 103: 577-590.
59. Dawe RK, Sedat JW, Agard DA, Cande WZ. Meiotic chromosome pairing in maize is associated with a novel chromatin organization. Cell 1994; 76: 901-912.